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OBJECTIVES: Advanced head and neck cancer (HNC) survivors may have perma-
nent alteration in their ability to communicate with others. Health-related quality
of life (HrQOL) outcomes have been emphasized as an important issue in cancer
survivors. This study compared HrQOL of the HNC survivors (five years after pri-
mary treatments) who had speech problem (SP) to who did not (NSP). We also
explored sensitivity of HrQOL instruments relative to this problem. METHODS:
This study was observational, mailed survey study. Target samples were individ-
uals who received HNC treatments before 2005. We identified subjects through the
Central Arkansas Radiation Therapy Institute Registry or recurited by phiysicinas
of the university Head and Neck Surgery Unit. Self-perceived speech problem and
HNC-specific HrQOL outcomes were determined using the University of Washing-
ton Quality of Life Questionnaire (UW-QOL) version 4. HrQOL outcomes were also
described using the EQ-5D and the SF-6D. A rank analysis of covariance was per-
formed to test for differences between the two groups on HrQOL outcomes, ad-
justed for years after treatment, treatment received, and cancer site. We expected
that a sensitive HrQOL instrument would produce significant lower HrQOL scores
for the SP group when compared to the NSP group at p-value  0.05. RESULTS:
Forty-seven HNC survivors’ HrQOL were analyzed (78% response rate). Survivors’
age averaged 65 years (SD13) and the average years after the primary treatment
was 8 years (SD2). 16 (34%) reported having speech problems (SP group). The
UW-QOL-Composite and the SF-6D scores in the SP group were significant lower
than the NSP group (6216 vs. 7815, p0.007; 0.660.12 vs. 0.780.16, p 0.023).
While there was no difference on the EQ-5D scores between the two groups
(0.780.16 (SP) versus 0.840.14 (NSP), p0.252). CONCLUSIONS: HNC survivors
with self-perceived speech problem reported significant lower HrQOL. The UW-
QOL and the SF-6D are sensitive to detect HrQOL difference relative to speech
problem.
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OBJECTIVES:This study was performed to examine the psychometric performance
of the four VISTAS-18 scales (i.e., Near Function, Intermediate Function, Extended-
Intermediate Function, Distant Function) to the known benefits of intraocular lens
(IOL) surgery, and more subtle differences between monofocal and multifocal IOL
types. METHODS: Subjects (Ss) were recruited from surgery clinics 2-8 weeks prior
to receiving bilateral IOL implants. Visual assessments were conducted at the pre-
surgical visit and then after recovery. Following both visits, Ss completed a self-
report questionnaire and the VISTAS item pool. The four VISTAS-18 Function Scale
scores were evaluated using change from baseline in visual acuity assessments,
and as well the type of IOL implant. Responder analyses were conducted for each
distance range. RESULTS: Ss (n61) had a mean age of 69.0 years (SD 9.5) were in
good health prior to surgery, although with low satisfaction with their vision and
very low satisfaction with their visual aids. Most Ss received monofocal (n39) or
multifocal (n16) lenses. Uncorrected and corrected visual function improved sig-
nificantly following surgery on all four VISTAS-18 scales. Greater improvements
were observed on the Near (p0.007) and Intermediate (p0.017) Function Scales
for recipients of multifocal versus monofocal lens. The responder analyses indi-
cated that 10/15 (66%) individuals who received multifocal lenses reported a one or
more point reduction in near range task difficulty, and 11/15 (73%) in the interme-
diate range, compared to only 10/35 (29%) and 16/30 (53%) of individuals receiving
monofocal implants. CONCLUSIONS: The VISTAS-18 Function Scales performed
well, both in terms of changes in visual acuity associated with IOL implantation, as
well as in demonstration of responsiveness to more subtle differences in Near and
Intermediate function associated with lens type. The clinical implications of reli-
able assessment of visual tasks in near, intermediate and distant ranges of vision
are discussed.
PSU23
REHABILITATION NEEDS AND PREDICTIVE FACTORS OF HEALTH-RELATED
QUALITY-OF-LIFE IN BREAST CANCER PATIENTS DURING TWO YEARS AFTER
SURGERY - A MULTICENTER PROSPECTIVE STUDY
Shimozuma K1, Taira N2, Shiroiwa T1, Ohsumi S3, Kuroi K4, Saito S5
1Ritsumeikan University, Kusatsu, Shiga, Japan, 2Okayama University Hospital, Okayama,
Okayama, Japan, 3National Hospital Organization, National Shikoku Cancer Center,
Matsushima, Ehime, Japan, 4Tokyo Metropolitan Cancer and Infectious Diseases Center
Komagome Hospital, Tokyo, Tokyo, Japan, 5Okayama University, Okayama, Okayama, Japan
OBJECTIVES: Provision of psychosocial support and rehabilitation for patients after
cancer treatment is important for long-term health-related quality-of-life (HRQOL).
Effective use of healthcare resources requires identification of patients requiring
rehabilitation. The objectives of this study were to clarify the patterns of physical
and psychosocial recovery over time and to identify the significant baseline and
treatment-related factors predicting HRQOL at 6 months, 1 and 2 years after breast
cancer surgery. METHODS: A multicenter longitudinal study was performed to
evaluate physical conditions, anxiety, depression and HRQOL at one month, 6
months, and 1 and 2 years after surgery in 196 breast cancer patients. Physical
conditions were evaluated using a patient-reported symptom checklist. HRQOL
was rated using the Functional Assessment of Cancer Therapy scale-General
(FACT-G) and the Breast Cancer subscale. Anxiety and depression were rated using
the Hospital Anxiety and Depression Scale (HADS). RESULTS: More than 50% of
patients had local problems of tightness, arm weakness and arm lymphedema,
and systemic problems of reduced energy, fatigue, and general weakness postop-
eratively. The HRQOL score significantly improved one year after surgery, and
scores for physical, emotional and functional well-being also increased with time,
whereas the score for social well-being was highest at baseline and decreased with
time. Depression and anxiety significantly improved with time. Concomitant dis-
ease, marital status and the presence of a partner, anxiety and depression at base-
line, pathological lymph node involvement, and adjuvant intravenous chemother-
apy were significant factors predicting FACT-G scores at 6 months and 1 and 2 years
after surgery. Depression at baseline was a strong predictor of HRQOL up to 2 years
after surgery. CONCLUSIONS: These results suggest that physical rehabilitation is
required for tightness and lymphedema, and a further study of psychosocial inter-
ventions is required to improve depression and social well-being.
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OBJECTIVES: To compare the responsiveness of the generic Short Form 36 (SF-36)
and the raw and Rasch-based scores of the condition-specific Oxford Knee Score
(OKS) in patients undergoing total knee replacement (TKR) METHODS: Adult pa-
tients undergoing TKR in a hospital of Singapore between 2001 and 2006 completed
the SF-36 and OKS at baseline and at 6 and 24 months postoperatively. OKS data
were fitted to the Rasch partial credit model using the Winsteps program. Respon-
siveness was assessed using effect size (ES), standardised response mean (SRM),
and relative validity (RV). RESULTS: A total of 702 patients who had complete data
at baseline and two follow-ups were included in the analysis. After removing items
regarding limping and kneeling, the remaining OKS items fit the Rasch model.
Bodily pain (BP) and Physical functioning (PF) were more responsive than the other
SF-36 domains. In addition, the OKS raw scores (raw-OKS) and Rasch-based mod-
ified OKS (Rasch-OKS) were consistently more responsive than all eight SF-36 do-
mains. At the 6-month follow-up, Rasch-OKS had the largest ES whereas raw-OKS
had the largest SRM (2.7 and 1.9, respectively). When compared to raw-OKS, the RV
of Rasch-OKS, BP, and PF were 1.5, 2.0, 2.8, respectively. Similar order was observed
at the 24-month follow-up. CONCLUSIONS: The OKS is more responsive than the
SF-36 in patients undergoing total knee replacement. The raw and Rasch-based
scores of OKS have comparable responsiveness. Different responsiveness indices
may give different results.
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OBJECTIVES: The main objective of this review is to determine the effectiveness of
total hip arthroplasty with MIS compare to the traditional approach. Specifically,
this appraisal aims to answer questions related to functionality, quality of life, and
clinical results.METHODS: The bibliographic review was conducted in two phases:
an initial phase of search for appropriate studies and a second phase of selection
according to previously established criteria. The search for articles was carried out
in major databases and subsequently in bibliographical references for the studies
found. The databases reviewed were MEDLINE/PubMed/MeSH Database, EMBASE,
Economic Evaluation Database/DARE/HTA, CSIC/EMI-Biomedicine, and ScienceDi-
rect Collection. The search period was limited to the years 2003 to 2009. The selec-
tion of items was made at an early stage by screening article summaries followed
by full texts. RESULTS: We initially selected more than 600 studies, 78 for detailed
evaluation, and 32 final studies for inclusion in the review. The results of this
review are presented in two sections. The first represents the main descriptive
characteristics of the studies selected in favor of MIS (19), and the second presents
the unfavorable studies (13). Among the main benefits we found a decrease of
transfusion requirements, better mobilization and rehabilitation, low dislocation,
reduced surgical time, shorter hospital stays, less soft tissue damage, and better
short term results. The main drawbacks were increased risks of complications,
malposition of prosthesis, healing problems, and irrelevant clinical incision size
and functionality. CONCLUSIONS: The studies presented in this review show clear
evidence of how MIS influences the effectiveness related to functional outcomes,
hospital stays, and surgical aggressiveness of the intervention. In this regard, we
found a greater number of comparable studies supporting minimally invasive sur-
gery in terms of effectiveness than those that emphasize complications and dis-
advantages of this technique.
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OBJECTIVES:The first objective was to assess the two-year changes in quality of life
after gastric bypass in patients with severe obesity. Second, we analysed the effect
of weight reduction on the different HRQL dimensions in the framework of the
International Classification of Functioning, Disability and Health (ICF). METHODS:
We carried out a prospective intervention study with consecutive patients referred
to two bariatric surgical units in the Basque Country. We included generic (SF-36,
EuroQuol 5D) and specific questionnaires (Moorehead-Ardelt, Obesity-related
Problems scale). The SF-36 mental and physical dimensions and stigma theory,
allowed us to apply an approach based on the ICF. We measured effect size (ES),
standardized response mean (SRM) and ROC curves. RESULTS: Of 82 operated pa-
tients, 79 were tracked for 2 years. Average weight loss was 49 kg (28%) and BMI was
reduced from 50.6 to 31.8. The initial problems and the final improvements were
larger in the physical dimensions. The benefit of treatment was large for almost all
HRQL domains as measured by EQ-5D, SF-36, OP and Moorehead-Ardelt. Only the
improvements in some of the mental domains of the SF-36 were classified as small
or moderate. ROC curves were not sensitive to change in BMI. CONCLUSIONS: We
suggest that the negative impact of severe obesity on HRQL is mainly a cause of
disability as described in the ICF. Two-year improvements in HRQL are related to
recovery from disability after gastric bypass treatment. The primary focus on the
physical dimension is not contradictory with evidence of the impact of weight-
related stigmatization in obese individuals at the social level and its consequences
in mental health. In the ICF framework,
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OBJECTIVES:The aim of our retrospective study was to analyze the further fracture
related treatment/complication after primary treatment of femur neck fracture
according to most frequently used types of operation. METHODS: The data derive
from the financial database of the Hungarian National Health Insurance Fund Ad-
ministration, based on the 10th revision of the International Classification of Dis-
eases (ICD) with ICD code S7200. The following patients were included into the
study: having social insurance identification number, being discharged from hos-
pitals in 2000 after primary treatment of femur neck fracture, over the age 60. The
patients with polytrauma or high energy trauma patient were excluded from the
study. During the 8 year follow up period the further fracture related treatment and
complications were analyzed according to the most frequently used types of
operation. RESULTS: Altogether 3783 patients were included into the study. The
distribution of primary surgical intervention was: arthroplasty 12.5%, screw fixa-
tion 73.6%, dynamic hip screw (DHS) 5.1%, femoral neck nailing 5.0%, Ender nailing
1.8%, Gamma nailing 1%, others 1 %. The fracture related treatment rate was 14,5%.
The main types of further fracture related treatments are listed: 5.7% hip replace-
ment, metalwork removal 3.6%, replacement of implants 2.48%, aseptic and septic
look: 1.7%, 0.7% resection arthroplasties. The further fracture related treatment
rate according to the most frequently used types of operation: arthroplasty 4.8 %,
screw fixation: 16.1 %, DHS: 7.8%, femoral neck nailing: 21.5%, Ender nailing: 19.4 %,
Gamma nailing: 2.4%. CONCLUSIONS: The methods, providing quickly full weight
bearing (Gamma nailing, DHS, hip arthroplasty) had lower complication rate, while
the methods (screw fixation, Ender nailing, femoral neck nailing) providing partial
weight bearing had higher complication rate. The backgrounds of fracture related
treatments should be investigated in the future.
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OBJECTIVES: Brain metastases occur in a majority of patients with malignant
disease and result in decreased quantity and quality of life. Treatment alterna-
tives range from whole brain radiation therapy (WBRT), neurosurgery, and the
newest modality, stereotactic radiosurgery (SRS). This article reviews economic
evaluations of SRS in the metastatic setting and compares to other treatment
options. METHODS: Studies were included if they were published in peer reviewed
journals, primarily in patients with malignant brain metastasis, and at least in-
cluded a cost analysis between interventions RESULTS: Uncertainty surrounding
the cost-effectiveness of SRS exits due to lack of efficacy information between
treatment alternatives, methodological limitations, and design differences be-
tween the available studies. However, when cost –effectiveness ratios are avail-
able, SRS appears to be a reasonable option in resource limited settings, with in-
cremental cost-effectiveness ratios (ICERS) just below the $50,000 range.
CONCLUSIONS: Better designed economic analysis in the setting of randomized
clinical trials or observational studies need to be conducted to fully understand the
economic value of SRS.
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OBJECTIVES: Thailand has been one of the leading developing countries to imple-
ment a national program to prevent mother-to-child transmission (PMTCT) of HIV.
The objective of this study was to determine the impact of pharmacist intervention
to monitor HIV-infected pregnant women. Pharmacist provided medication and
guideline information including phamacotherapeutic suggestion. METHODS: In
this research, retrospective study was employed with descriptive statistics using
average percentage frequency, making use of out-patients records of treatments in
HIV-infected pregnant women who informed about the benefits of taking antiret-
roviral (ARV) drugs for PMTCT, side effects of ARV drugs, importance of adherence
to drugs and the fact that HIV transmission to their infants can possibly occur
despite ARV use by pharmacist. RESULTS: The HIV-infected pregnant women
group of 24 cases, 4 were withdrawn due to unable to follow up, 20 cases have been
followed-up and shown the effectiveness of medicine. There were 8 new patients
(33.33%) firstly received ARV. The mean CD4 cell counts at baseline of all patients
were 227-69.28 cells/mm3. Most regimens for treatment was highly active anti-
retroviral therapy containing zidovudine (AZT)lamivudine (3TC)lopinavir/
ritonavir (LPV/rtv) 41.67% where treated with AZT3TCnevirapine were secondly
used (33.33%). It was found that 34.4% of patients had adverse drug reactions. The
ADR incidence of ARV was 4.0 patients and 6.2 events per 1000 person-day. Gas-
trointestinal system such as nausea and vomiting were found at 12.50% and 8.33%
were diarrhea were the most organ system affected. During the study period, 3
patients had to change ARV regimens because of ADRs. 16.67% were non-compli-
ance but less than 7 days at early period. The rate of MTCT of HIV was 8.33% after
monitoring for one year. CONCLUSIONS: The results indicated that a medication
monitoring and evaluating process by pharmacist associated with improved ratio-
nal used of drug in HIV-infected pregnant women. This project provides a founda-
tion for future quality improvement.
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OBJECTIVES: The aim of this study was to assess efficacy and safety of tenofovir
(TDF) as compared to other nucleot(s)ide analogues (NAs), i.e. lamivudine (LAM),
adefovir (ADV) and entecavir (ETV) in the treatment of chronic hepatitis B virus
(HBV) infection.METHODS:Assessment was based on randomized controlled trials
(RCTs) identified by means of systematic review, carried out according to the Co-
chrane Collaboration guidelines. Studies met the inclusion criteria if they directly
compared at least two of following interventions: TDF, LAM, ADV, ETV or placebo.
The electronic medical databases (EMBASE, MEDLINE, CENTRAL) were searched.
Two reviewers independently selected trials, assessed their quality and extracted
data. Mixed treatment comparison (MTC) was performed with WinBugs software. If
feasible, subgroup analyses were performed according to hepatitis B antigen e
(HBeAg) and or LAM resistance status. RESULTS: We identified 30 relevant studies
(6674 patients) with 12-144 weeks of follow-up . MTC showed that TDF increased
the chance of HBV DNA clearance at the end of treatment period as compared to
ADV (OR  13,16 [3,21; 54,20]), LAM (OR  61,09 [11,10; 503,78]) and ETV (OR  9,55
[1,53; 76,98]). Subgroup analysis in HBeAg-positive subjects revealed that TDV was
more effective than ADV (OR  21,60 [1,67; 285,40]) and LAM with respect to HBV
DNA clearance but no difference were found between TDV and ETV (OR  11,24
[0,53; 342,57). TDF showed similar efficacy to other NAs with respect to normaliza-
tion of alanine aminotransferase activity (ALT) and histological improvement. TDF
did not increase the risk of any and serious adverse events either in comparison
with PLC or with other NAs. The rates of ALT flares were similar in all groups.
CONCLUSIONS:TDF demonstrated the highest efficacy with respect to reduction of
viral load in patients with chronic HBV and maintained a very good safety profile.
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OBJECTIVES:A framework for comparative research is useful for health technology
assessment (HTA) and clinical decision making. The objective was to systemati-
cally assess efficacy and tolerability of 3rd agents, atazanavir/r (ATV/r) compared to
darunavir/r (DRV/r), lopinavir/r (LPV/r) and efavirenz (EFV), in treatment-naïve
HIV-1 infected adults. METHODS: A systematic literature search was conducted to
identify published randomized clinical trials (1-1-2000 to present), in which the
four anti-retroviral (ARV) treatments were used for these patients. Pooled esti-
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